Australia

Covid vaccine tracker: when will we have a coronavirus vaccine?

Sun, 2020-08-16 10:46 — mike kraft

Covid vaccine tracker: when will we have a coronavirus vaccine? More than 170 teams of researchers are racing to develop a safe and effective vaccine. Here is their progress the Guardian

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Covid vaccine tracker: when will we have a coronavirus vaccine?
Log in or register to post comments

Asia Today: Restrictions in S. Korea, India cases hit 2.5M

Sat, 2020-08-15 14:31 — mike kraft

Asia Today: Restrictions in S. Korea, India cases hit 2.5M SEOUL, South Korea (AP) — South Korea on Saturday announced stronger social distancing restrictions for its greater capital area where a surge in COVID-19 cases has threatened to erase the... AP NEWS

SEOUL, South Korea (AP) — South Korea on Saturday announced stronger social distancing restrictions for its greater capital area where a surge in COVID-19 cases has threatened to erase the hard-won gains against the virus.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Asia Today: Restrictions in S. Korea, India cases hit 2.5M
Log in or register to post comments

ANALYSIS: Detailed discussion of ways to speed coronavirus testing.

Fri, 2020-08-14 21:14 — mike kraft

The Plan That Could Give Us Our Lives Back The U.S. has never had enough coronavirus tests. Now a group of epidemiologists, economists, and dreamers is plotting a new strategy to defeat the virus, even before a vaccine is found. Robinson Meyer and Alexis C. Madrigal The Atlantic

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Solutions

Read more about ANALYSIS: Detailed discussion of ways to speed coronavirus testing.
1 comment
Log in or register to post comments

CDC estimates three-month window of immunity after COVID-19 infection

Fri, 2020-08-14 19:37 — mike kraft

CDC gives three-month window of immunity after COVID-19 infection A person who has recovered from COVID-19 will likely be safe from reinfection for three months, according to updated guidance from the Centers for Disease Control and Prevention (CDC). Nathaniel Weixel TheHill

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Read more about CDC estimates three-month window of immunity after COVID-19 infection
Log in or register to post comments

Clinical Trials of Coronavirus Drugs Are Taking Longer Than Expected

Fri, 2020-08-14 19:05 — mike kraft

As the coronavirus pandemic continues to wreak havoc in the United States and treatments are needed more than ever, clinical trials for some of the most promising experimental drugs are taking longer than expected.

Researchers at a dozen clinical trial sites said that testing delays, staffing shortages, space constraints and reluctant patients were complicating their efforts to test monoclonal antibodies, man-made drugs that mimic the molecular soldiers made by the human immune system.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Problem

Situation Report

Read more about Clinical Trials of Coronavirus Drugs Are Taking Longer Than Expected
Log in or register to post comments

Face masks with valves or vents do not prevent spread of the coronavirus, CDC says

Fri, 2020-08-14 12:50 — mike kraft

Face masks with valves or vents do not prevent spread of the coronavirus, CDC says "Masks with one-way valves or vents allow air to be exhaled through a hole in the material, which can result in expelled respiratory droplets that can reach others," the CDC says. Reis Thebault, Angela Fritz Washington Post

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Solutions

Situation Report

Read more about Face masks with valves or vents do not prevent spread of the coronavirus, CDC says
Log in or register to post comments

UPDATE: The U.S. has already invested billions in potential coronavirus vaccines. Here’s where the deals stand

Fri, 2020-08-14 10:52 — mike kraft

The U.S. has already invested billions in potential coronavirus vaccines. Here's where the deals stand The U.S. has doled out billions to develop a vaccine against the coronavirus, locking in a minimum of 800 million doses so far. Noah Higgins-Dunn CNBC

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

The Many Symptoms of Covid-19

Wed, 2020-08-12 16:24 — mike kraft

For a Texas nurse, the first sign that something was wrong happened while brushing her teeth — she couldn’t taste her toothpaste. For a Georgia attorney, it was hitting a wall of fatigue on a normally easy run. When a Wisconsin professor fell ill in June, he thought a bad meal had upset his stomach.

But eventually, all of these people discovered that their manifold symptoms were all signs of Covid-19. Some of the common symptoms — a dry cough, a headache — can start so mildly they are at first mistaken for allergies or a cold. In other cases, the symptoms are so unusual — strange leg pain, a rash or dizziness — that patients and even their doctors don’t think Covid-19 could be the culprit.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Problem

Read more about The Many Symptoms of Covid-19
Log in or register to post comments

Why does COVID-19 strike some and not others? Fauci sees an answer in new study

Tue, 2020-08-11 11:09 — mike kraft

Why does COVID-19 strike some and not others? Fauci sees an answer in new study Scientists believe they may have discovered why the novel coronavirus affects some people so much more than others. YahooNews

Dr. Anthony Fauci, the nation’s leading infectious disease expert, said a new study could explain the extraordinary range that people experience with the novel coronavirus, from having no symptoms at all or a mild case to hospitalization or death.

Country / Region Tags: